NASDAQ:CFMS
Delisted
ConforMIS Stock News
$2.26
+0 (+0%)
At Close: Nov 30, 2023
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
04:30pm, Monday, 29'th Aug 2022
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that
Conformis, Inc. (CFMS) CEO Mark Augusti on Q2 2022 Results - Earnings Call Transcript
11:55am, Tuesday, 09'th Aug 2022
Start Time: 08:30 January 1, 0000 8:57 AM ET Conformis, Inc. (NASDAQ:CFMS ) Q2 2022 Earnings Conference Call August 09, 2022, 08:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
10:05pm, Monday, 08'th Aug 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Conformis Reports Second Quarter 2022 Financial Results
08:45pm, Monday, 08'th Aug 2022 GlobeNewswire Inc.
BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
07:34pm, Monday, 08'th Aug 2022
ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket
10:39am, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Apexigen (NASDAQ: APGN) rose 37.2% to $29.28 in pre
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
08:30pm, Monday, 01'st Aug 2022 GlobeNewswire Inc.
Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
08:30pm, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today th
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
08:30pm, Tuesday, 05'th Jul 2022 GlobeNewswire Inc.
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
04:30pm, Tuesday, 05'th Jul 2022
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it wi
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
09:35am, Friday, 24'th Jun 2022 Benzinga
Gainers
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown offer
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 10'th May 2022
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that
Conformis, Inc. (CFMS) CEO Mark Augusti on Q1 2022 Results - Earnings Call Transcript
03:04pm, Wednesday, 04'th May 2022
Conformis, Inc. (NASDAQ:CFMS ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - Chief Financial Officer Conf
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -28.57% and 11.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?